Literature DB >> 33222247

Organoids and Spheroids as Models for Studying Cholestatic Liver Injury and Cholangiocarcinoma.

Burcin Ekser1, Gianfranco Alpini2,3, Keisaku Sato2, Wenjun Zhang1, Samira Safarikia4, Abdulkadir Isidan1, Angela M Chen1, Ping Li1, Heather Francis2,3, Lindsey Kennedy2, Leonardo Baiocchi5, Domenico Alvaro4, Shannon Glaser6.   

Abstract

Cholangiopathies, such as primary sclerosing cholangitis, biliary atresia, and cholangiocarcinoma, have limited experimental models. Not only cholangiocytes but also other hepatic cells including hepatic stellate cells and macrophages are involved in the pathophysiology of cholangiopathies, and these hepatic cells orchestrate the coordinated response against diseased conditions. Classic two-dimensional monolayer cell cultures do not resemble intercellular cell-to-cell interaction and communication; however, three-dimensional cell culture systems, such as organoids and spheroids, can mimic cellular interaction and architecture between hepatic cells. Previous studies have demonstrated the generation of hepatic or biliary organoids/spheroids using various cell sources including pluripotent stem cells, hepatic progenitor cells, primary cells from liver biopsies, and immortalized cell lines. Gene manipulation, such as transfection and transduction can be performed in organoids, and established organoids have functional characteristics which can be suitable for drug screening. This review summarizes current methodologies for organoid/spheroid formation and a potential for three-dimensional hepatic cell cultures as in vitro models of cholangiopathies.
© 2020 by the American Association for the Study of Liver Diseases.

Entities:  

Mesh:

Year:  2021        PMID: 33222247      PMCID: PMC8529583          DOI: 10.1002/hep.31653

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.298


  54 in total

1.  Gene manipulation in liver ductal organoids by optimized recombinant adeno-associated virus vectors.

Authors:  Jinsong Wei; Gai Ran; Xin Wang; Ning Jiang; Jianqing Liang; Xinhua Lin; Chen Ling; Bing Zhao
Journal:  J Biol Chem       Date:  2019-07-31       Impact factor: 5.157

2.  Identification of a plant isoflavonoid that causes biliary atresia.

Authors:  Kristin Lorent; Weilong Gong; Kyung A Koo; Orith Waisbourd-Zinman; Sara Karjoo; Xiao Zhao; Ian Sealy; Ross N Kettleborough; Derek L Stemple; Peter A Windsor; Stephen J Whittaker; John R Porter; Rebecca G Wells; Michael Pack
Journal:  Sci Transl Med       Date:  2015-05-06       Impact factor: 17.956

3.  Bioengineered bile ducts recapitulate key cholangiocyte functions.

Authors:  Chen Chen; Paulus G M Jochems; Lucia Salz; Kerstin Schneeberger; Louis C Penning; Stan F J van de Graaf; Ulrich Beuers; Hans Clevers; Niels Geijsen; Rosalinde Masereeuw; Bart Spee
Journal:  Biofabrication       Date:  2018-06-12       Impact factor: 9.954

4.  Modeling Steatohepatitis in Humans with Pluripotent Stem Cell-Derived Organoids.

Authors:  Rie Ouchi; Shodai Togo; Masaki Kimura; Tadahiro Shinozawa; Masaru Koido; Hiroyuki Koike; Wendy Thompson; Rebekah A Karns; Christopher N Mayhew; Patrick S McGrath; Heather A McCauley; Ran-Ran Zhang; Kyle Lewis; Shoyo Hakozaki; Autumn Ferguson; Norikazu Saiki; Yosuke Yoneyama; Ichiro Takeuchi; Yo Mabuchi; Chihiro Akazawa; Hiroshi Y Yoshikawa; James M Wells; Takanori Takebe
Journal:  Cell Metab       Date:  2019-05-30       Impact factor: 27.287

Review 5.  Mechanisms of cholangiocyte responses to injury.

Authors:  Keisaku Sato; Fanyin Meng; Thao Giang; Shannon Glaser; Gianfranco Alpini
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2017-06-23       Impact factor: 5.187

6.  The Secretin/Secretin Receptor Axis Modulates Ductular Reaction and Liver Fibrosis through Changes in Transforming Growth Factor-β1-Mediated Biliary Senescence.

Authors:  Nan Wu; Fanyin Meng; Tianhao Zhou; Julie Venter; Thao K Giang; Konstantina Kyritsi; Chaodong Wu; Domenico Alvaro; Paolo Onori; Romina Mancinelli; Eugenio Gaudio; Heather Francis; Gianfranco Alpini; Shannon Glaser; Antonio Franchitto
Journal:  Am J Pathol       Date:  2018-07-21       Impact factor: 4.307

7.  Pharmacokinetics of 5 (and 6)-carboxy-2',7'-dichlorofluorescein and its diacetate promoiety in the liver.

Authors:  Maciej J Zamek-Gliszczynski; Hao Xiong; Nita J Patel; Ryan Z Turncliff; Gary M Pollack; Kim L R Brouwer
Journal:  J Pharmacol Exp Ther       Date:  2003-02       Impact factor: 4.030

Review 8.  Animal models for liver disease - A practical approach for translational research.

Authors:  Yulia A Nevzorova; Zoe Boyer-Diaz; Francisco Javier Cubero; Jordi Gracia-Sancho
Journal:  J Hepatol       Date:  2020-04-21       Impact factor: 25.083

9.  Long-term culture of genome-stable bipotent stem cells from adult human liver.

Authors:  Meritxell Huch; Helmuth Gehart; Ruben van Boxtel; Karien Hamer; Francis Blokzijl; Monique M A Verstegen; Ewa Ellis; Martien van Wenum; Sabine A Fuchs; Joep de Ligt; Marc van de Wetering; Nobuo Sasaki; Susanne J Boers; Hans Kemperman; Jeroen de Jonge; Jan N M Ijzermans; Edward E S Nieuwenhuis; Ruurdtje Hoekstra; Stephen Strom; Robert R G Vries; Luc J W van der Laan; Edwin Cuppen; Hans Clevers
Journal:  Cell       Date:  2014-12-18       Impact factor: 41.582

10.  Mutant IDH1 confers resistance to energy stress in normal biliary cells through PFKP-induced aerobic glycolysis and AMPK activation.

Authors:  Hiroaki Fujiwara; Keisuke Tateishi; Kento Misumi; Akimasa Hayashi; Kaori Igarashi; Hiroyuki Kato; Takuma Nakatsuka; Nobumi Suzuki; Keisuke Yamamoto; Yotaro Kudo; Yoku Hayakawa; Hayato Nakagawa; Yasuo Tanaka; Hideaki Ijichi; Hirofumi Kogure; Yosuke Nakai; Hiroyuki Isayama; Kiyoshi Hasegawa; Masashi Fukayama; Tomoyoshi Soga; Kazuhiko Koike
Journal:  Sci Rep       Date:  2019-12-11       Impact factor: 4.379

View more
  10 in total

Review 1.  Development and Characterization of Human Primary Cholangiocarcinoma Cell Lines.

Authors:  Abdulkadir Isidan; Ali Yenigun; Daiki Soma; Eric Aksu; Kevin Lopez; Yujin Park; Arthur Cross-Najafi; Ping Li; Debjyoti Kundu; Michael G House; Sanjukta Chakraborty; Shannon Glaser; Lindsey Kennedy; Heather Francis; Wenjun Zhang; Gianfranco Alpini; Burcin Ekser
Journal:  Am J Pathol       Date:  2022-05-28       Impact factor: 5.770

Review 2.  Recent discoveries in microbiota dysbiosis, cholangiocytic factors, and models for studying the pathogenesis of primary sclerosing cholangitis.

Authors:  Yu Huang; Shuai Zhang; Jie-Feng Weng; Di Huang; Wei-Li Gu
Journal:  Open Med (Wars)       Date:  2022-05-13

Review 3.  Targeting Lymphangiogenesis and Lymph Node Metastasis in Liver Cancer.

Authors:  Sukanya Roy; Priyanka Banerjee; Burcin Ekser; Kayla Bayless; David Zawieja; Gianfranco Alpini; Shannon S Glaser; Sanjukta Chakraborty
Journal:  Am J Pathol       Date:  2021-09-09       Impact factor: 4.307

Review 4.  Moving forward in the treatment of cholangiocarcinoma.

Authors:  Tommaso M Manzia; Alessandro Parente; Ilaria Lenci; Bruno Sensi; Martina Milana; Carlo Gazia; Alessandro Signorello; Roberta Angelico; Giuseppe Grassi; Giuseppe Tisone; Leonardo Baiocchi
Journal:  World J Gastrointest Oncol       Date:  2021-12-15

Review 5.  Applied Hepatic Bioengineering: Modeling the Human Liver Using Organoid and Liver-on-a-Chip Technologies.

Authors:  Kayque Alves Telles-Silva; Lara Pacheco; Sabrina Komatsu; Fernanda Chianca; Luiz Carlos Caires-Júnior; Bruno Henrique Silva Araujo; Ernesto Goulart; Mayana Zatz
Journal:  Front Bioeng Biotechnol       Date:  2022-02-14

Review 6.  3D and organoid culture in research: physiology, hereditary genetic diseases and cancer.

Authors:  Elisa Suarez-Martinez; Irene Suazo-Sanchez; Manuel Celis-Romero; Amancio Carnero
Journal:  Cell Biosci       Date:  2022-04-01       Impact factor: 7.133

7.  Kuhuang injection exerts a protective effect by activating PPAR-γ in an in vitro model of chlorpromazine-induced cholestatic liver injury constructed by tissue engineering.

Authors:  Qiao Wu; Zhongping Duan; Long Huang; Zhijie Li
Journal:  Pharm Biol       Date:  2022-12       Impact factor: 3.889

Review 8.  Applications of human organoids in the personalized treatment for digestive diseases.

Authors:  Qinying Wang; Fanying Guo; Yutao Jin; Yanlei Ma
Journal:  Signal Transduct Target Ther       Date:  2022-09-27

Review 9.  Molecular Mechanisms Linking Risk Factors to Cholangiocarcinoma Development.

Authors:  Ludovica Ceci; Tianhao Zhou; Ilaria Lenci; Vik Meadows; Lindsey Kennedy; Ping Li; Burcin Ekser; Martina Milana; Wenjun Zhang; Chaodong Wu; Keisaku Sato; Sanjukta Chakraborty; Shannon S Glaser; Heather Francis; Gianfranco Alpini; Leonardo Baiocchi
Journal:  Cancers (Basel)       Date:  2022-03-11       Impact factor: 6.639

Review 10.  Current Advances in Basic and Translational Research of Cholangiocarcinoma.

Authors:  Keisaku Sato; Leonardo Baiocchi; Lindsey Kennedy; Wenjun Zhang; Burcin Ekser; Shannon Glaser; Heather Francis; Gianfranco Alpini
Journal:  Cancers (Basel)       Date:  2021-07-01       Impact factor: 6.639

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.